{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:32:50Z","timestamp":1792481570115,"version":"4.5.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1038\/nrcardio.2015.22","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T10:27:20Z","timestamp":1424773640000},"page":"278-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Pathophysiology and clinical management of cardiac sarcoidosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Nabeel","family":"Hamzeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Steckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"key":"BFnrcardio201522_CR1","first-page":"149","volume":"16","author":"GW Hunninghake","year":"1999","unstructured":"Hunninghake, G. W. et al. ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung. Dis. 16, 149\u2013173 (1999).","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"BFnrcardio201522_CR2","unstructured":"Statement on Sarcoidosis. Am. J. Respir. Crit. Care Med. 160, 736\u2013755 (1999)."},{"key":"BFnrcardio201522_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ccm.2008.03.014","volume":"29","author":"AK Gerke","year":"2008","unstructured":"Gerke, A. K. & Hunninghake, G. The immunology of sarcoidosis. Clin. Chest Med. 29, 379\u2013390 (2008).","journal-title":"Clin. Chest Med."},{"key":"BFnrcardio201522_CR4","first-page":"377","volume":"43","author":"K Iwai","year":"1993","unstructured":"Iwai, K., Takemura, T., Kitaichi, M., Kawabata, Y. & Matsui, Y. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol. Jpn. 43, 377\u2013385 (1993).","journal-title":"Acta Pathol. Jpn."},{"key":"BFnrcardio201522_CR5","first-page":"167","volume":"119","author":"A Perry","year":"1995","unstructured":"Perry, A. & Vuitch, F. Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations. Arch. Pathol. Lab. Med. 119, 167\u2013172 (1995).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrcardio201522_CR6","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman, K. J., Hutchins, G. M. & Bulkley, B. H. Cardiac sarcoid: a clinicopathological study of 84 unselected patients with systemic sarcoidosis. Circulation 58, 1204\u20131211 (1978).","journal-title":"Circulation"},{"key":"BFnrcardio201522_CR7","first-page":"26","volume":"11","author":"K Iwai","year":"1994","unstructured":"Iwai, K. et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11, 26\u201331 (1994).","journal-title":"Sarcoidosis"},{"key":"BFnrcardio201522_CR8","first-page":"231","volume":"62","author":"CT Huang","year":"1981","unstructured":"Huang, C. T., Heurich, A. E., Sutton, A. L. & Lyons, H. A. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur. J. Respir. Dis. 62, 231\u2013238 (1981).","journal-title":"Eur. J. Respir. Dis."},{"key":"BFnrcardio201522_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","volume":"104","author":"F Tavora","year":"2009","unstructured":"Tavora, F. et al. Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes. Am. J. Cardiol. 104, 571\u2013577 (2009).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201522_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ahj.2008.09.009","volume":"157","author":"JS Kim","year":"2009","unstructured":"Kim, J. S. et al. Cardiac sarcoidosis. Am. Heart. J. 157, 9\u201321 (2009).","journal-title":"Am. Heart. J."},{"key":"BFnrcardio201522_CR11","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1378\/chest.07-2784","volume":"133","author":"D Mehta","year":"2008","unstructured":"Mehta, D. et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133, 1426\u20131435 (2008).","journal-title":"Chest"},{"key":"BFnrcardio201522_CR12","first-page":"119","volume":"29","author":"MA Judson","year":"2012","unstructured":"Judson, M. A., Boan, A. D. & Lackland, D. T. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc. Diffuse Lung. Dis. 29, 119\u2013127 (2012).","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"BFnrcardio201522_CR13","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman, R. P. et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care. Med. 164, 1885\u20131889 (2001).","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"BFnrcardio201522_CR14","first-page":"75","volume":"16","author":"MA Judson","year":"1999","unstructured":"Judson, M. A., Baughman, R. P., Teirstein, A. S., Terrin, M. L. & Yeager, H. Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc. Diffuse Lung. Dis. 16, 75\u201386 (1999).","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"BFnrcardio201522_CR15","first-page":"125","volume":"25","author":"MD Rossman","year":"2008","unstructured":"Rossman, M. D. et al. HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung. Dis. 25, 125\u2013132 (2008).","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"BFnrcardio201522_CR16","first-page":"36","volume":"30","author":"H Kuroda","year":"2013","unstructured":"Kuroda, H. et al. Relationship between cytokine single nucleotide polymorphisms and sarcoidosis among Japanese subjects. Sarcoidosis Vasc. Diffuse Lung. Dis. 30, 36\u201342 (2013).","journal-title":"Sarcoidosis Vasc. Diffuse Lung. Dis."},{"key":"BFnrcardio201522_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1034\/j.1399-0039.2000.560107.x","volume":"56","author":"TK Naruse","year":"2000","unstructured":"Naruse, T. K. et al. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 56, 52\u201357 (2000).","journal-title":"Tissue Antigens"},{"key":"BFnrcardio201522_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1034\/j.1399-0039.1999.540211.x","volume":"54","author":"N Takashige","year":"1999","unstructured":"Takashige, N. et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 54, 191\u2013193 (1999).","journal-title":"Tissue Antigens"},{"key":"BFnrcardio201522_CR19","doi-asserted-by":"publisher","unstructured":"Kandolin, R. et al. Cardiac sarcoidosis: epidemiology, characteristics and outcome over 25 years in a nationwide study. Circulation http:\/\/dx.doi.org\/10.1161\/CIRCULATIONAHA.114.011522 .","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"BFnrcardio201522_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0002-8703(79)90004-8","volume":"97","author":"V Abeler","year":"1979","unstructured":"Abeler, V. Sarcoidosis of the cardiac conducting system. Am. Heart J. 97, 701\u2013707 (1979).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201522_CR21","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/0735-1097(91)90750-4","volume":"18","author":"SL Winters","year":"1991","unstructured":"Winters, S. L. et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of the underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy and an implantable antitachycardia device. J. Am. Coll. Cardiol. 18, 937\u2013943 (1991).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201522_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","volume":"3","author":"BA Koplan","year":"2006","unstructured":"Koplan, B. A., Soejima, K., Baughman, K., Epstein, L. M. & Stevenson, W. G. Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation. Heart Rhythm 3, 924\u2013929 (2006).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201522_CR23","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","volume":"4","author":"K Banba","year":"2007","unstructured":"Banba, K. et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 4, 1292\u20131299 (2007).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201522_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.hrthm.2008.10.039","volume":"6","author":"D Jefic","year":"2009","unstructured":"Jefic, D. et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm 6, 189\u2013195 (2009).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201522_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/clc.4960270409","volume":"27","author":"H Furushima","year":"2004","unstructured":"Furushima, H. et al. Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome. Clin. Cardiol. 27, 217\u2013222 (2004).","journal-title":"Clin. Cardiol."},{"key":"BFnrcardio201522_CR26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/europace\/eun110","volume":"10","author":"P Uusimaa","year":"2008","unstructured":"Uusimaa, P. et al. Ventricular tachyarrhythmia as a primary presentation of sarcoidosis. Europace 10, 760\u2013766 (2008).","journal-title":"Europace"},{"key":"BFnrcardio201522_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","volume":"7","author":"Y Naruse","year":"2014","unstructured":"Naruse, Y. et al. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Circ. Arrhythm. Electrophysiol. 7, 407\u2013413 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201522_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCEP.113.000156","volume":"7","author":"T Crawford","year":"2014","unstructured":"Crawford, T. et al. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias. Circ. Arrhythm. Electrophysiol. 7, 1109\u20131115 (2014).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201522_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jjcc.2012.08.002","volume":"60","author":"MA Shafee","year":"2012","unstructured":"Shafee, M. A. et al. Delayed enhancement on cardiac magnetic resonance imaging is a poor prognostic factor in patients with cardiac sarcoidosis. J. Cardiol. 60, 448\u2013453 (2012).","journal-title":"J. Cardiol."},{"key":"BFnrcardio201522_CR30","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","volume":"5","author":"M Tokuda","year":"2012","unstructured":"Tokuda, M. et al. Catheter ablation of ventricular tachycardia in nonischemic heart disease. Circ. Arrhythm. Electrophysiol. 5, 992\u20131000 (2012).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201522_CR31","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/jce.12424","volume":"25","author":"JM Willner","year":"2014","unstructured":"Willner, J. M., Viles-Gonzalez, J. F., Coffey, J. O., Morgenthau, A. S. & Mehta, D. Catheter ablation of atrial arrhythmias in cardiac sarcoidosis. J. Cardiovasc. Electrophysiol. 25, 958\u2013963 (2014).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201522_CR32","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1378\/chest.11-3214","volume":"143","author":"JF Viles-Gonzalez","year":"2013","unstructured":"Viles-Gonzalez, J. F. et al. Supraventricular arrhythmias in patients with cardiac sarcoidosis prevalence, predictors, and clinical implications. Chest 143, 1085\u20131090 (2013).","journal-title":"Chest"},{"key":"BFnrcardio201522_CR33","doi-asserted-by":"publisher","first-page":"E727","DOI":"10.1016\/S0735-1097(12)60728-1","volume":"59","author":"M Cain","year":"2012","unstructured":"Cain, M. et al. Are atrial arrhythmias under-recognized in patients with cardiac sarcoidosis? [abstract] J. Am. Coll. Cardiol. 59, E727 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201522_CR34","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","volume":"113","author":"MA Cain","year":"2014","unstructured":"Cain, M. A. et al. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias. Am. J. Cardiol. 113, 1556\u20131560 (2014).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201522_CR35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5114\/aoms.2011.24118","volume":"7","author":"V Sekhri","year":"2011","unstructured":"Sekhri, V., Sanal, S., Delorenzo, L. J., Aronow, W. S. & Maguire, G. P. Cardiac sarcoidosis: a comprehensive review. Arch. Med. Sci. 7, 546\u2013554 (2011).","journal-title":"Arch. Med. Sci."},{"key":"BFnrcardio201522_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hrthm.2012.11.023","volume":"2013","author":"M Zipse","year":"2013","unstructured":"Zipse, M. et al. Atrial arrhythmias are common and arise from diverse mechanisms in patients with cardiac sarcoidosis. Heart Rhythm 2013, 1\u20132 (2013).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201522_CR37","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","volume":"64","author":"CT January","year":"2014","unstructured":"January, C. T. et al. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 64, e1\u2013e76 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201522_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1540-8159.2011.03227.x","volume":"35","author":"AB Biviano","year":"2012","unstructured":"Biviano, A. B. et al. Focal left atrial tachycardias not associated with prior catheter ablation for atrial fibrillation: clinical and electrophysiological characteristics. Pacing Clin. Electrophysiol. 35, 17\u201327 (2012).","journal-title":"Pacing Clin. Electrophysiol."},{"key":"BFnrcardio201522_CR39","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/jce.12401","volume":"25","author":"PB Nery","year":"2014","unstructured":"Nery, P. B. et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults. J. Cardiovasc. Electrophysiol. 25, 875\u2013881 (2014).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201522_CR40","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S0002-8703(97)70070-X","volume":"134","author":"Y Yoshida","year":"1997","unstructured":"Yoshida, Y. et al. Incidence of cardiac sarcoidosis in Japanese patients with high-degree atrioventricular block. Am. Heart J. 134, 382\u2013386 (1997).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201522_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","volume":"4","author":"R Kandolin","year":"2011","unstructured":"Kandolin, R., Lehtonen, J. & Kupari, M. Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults. Circ. Arrhythm. Electrophysiol. 4, 303\u2013309 (2011).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201522_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/01.md.0000145367.17934.75","volume":"83","author":"C Chapelon-Abric","year":"2004","unstructured":"Chapelon-Abric, C. et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83, 315\u2013334 (2004).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrcardio201522_CR43","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","volume":"106","author":"T Suzuki","year":"1994","unstructured":"Suzuki, T., Kanda, T., Kubota, S., Imai, S. & Murata, K. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 106, 1021\u20131024 (1994).","journal-title":"Chest"},{"key":"BFnrcardio201522_CR44","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/j.1540-8167.2011.02099.x","volume":"22","author":"JL Schuller","year":"2011","unstructured":"Schuller, J. L. et al. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement. J. Cardiovasc. Electrophysiol. 22, 1243\u20131248 (2011).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201522_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1542-474X.2009.00320.x","volume":"14","author":"H Mohamed","year":"2009","unstructured":"Mohamed, H., Lamaan, A., Bilal, S., Jo, M. & Mithilesh, K. D. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging. Ann. Noninvasive Electrocardiol. 14, 319\u2013326 (2009).","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"BFnrcardio201522_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4236\/ijcm.2013.49070","volume":"04","author":"E Gialafos","year":"2013","unstructured":"Gialafos, E. et al. P wave analysis in patients with sarcoidosis. Int. J. Clin. Med. 04, 388\u2013394 (2013).","journal-title":"Int. J. Clin. Med."},{"key":"BFnrcardio201522_CR47","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1536\/ihj.50.731","volume":"50","author":"S Matsumoto","year":"2009","unstructured":"Matsumoto, S. et al. Noninvasive diagnosis of cardiac sarcoidosis using microvolt T-wave alternans. Int. Heart J. 50, 731\u2013739 (2009).","journal-title":"Int. Heart J."},{"key":"BFnrcardio201522_CR48","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1055\/s-0030-1262211","volume":"31","author":"H Nunes","year":"2010","unstructured":"Nunes, H. et al. Cardiac sarcoidosis. Semin. Respir. Crit. Care Med. 31, 428\u2013441 (2010).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"BFnrcardio201522_CR49","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00408-014-9586-5","volume":"192","author":"S Kul","year":"2014","unstructured":"Kul, S. et al. Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis. Lung 192, 533\u2013542 (2014).","journal-title":"Lung"},{"key":"BFnrcardio201522_CR50","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijcard.2004.05.028","volume":"102","author":"H Yasutake","year":"2005","unstructured":"Yasutake, H. et al. Detection of cardiac sarcoidosis using cardiac markers and myocardial integrated backscatter. Int. J. Cardiol. 102, 259\u2013268 (2005).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201522_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000095518","volume":"107","author":"T Date","year":"2007","unstructured":"Date, T. et al. Elevated plasma brain natriuretic peptide level in cardiac sarcoidosis patients with preserved ejection fraction. Cardiology 107, 277\u2013280 (2007).","journal-title":"Cardiology"},{"key":"BFnrcardio201522_CR52","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1536\/ihj.53.287","volume":"53","author":"Y Baba","year":"2012","unstructured":"Baba, Y. et al. Usefulness of high-sensitive cardiac troponin T for evaluating the activity of cardiac sarcoidosis. Int. Heart J. 53, 287\u2013292 (2012).","journal-title":"Int. Heart J."},{"key":"BFnrcardio201522_CR53","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie, D. H. et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11, 1305\u20131323 (2014).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201522_CR54","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","volume":"45","author":"JP Smedema","year":"2005","unstructured":"Smedema, J. P. et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J. Am. Coll. Cardiol. 45, 1683\u20131690 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201522_CR55","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/eurjhf\/hfs206","volume":"15","author":"A Yoshida","year":"2013","unstructured":"Yoshida, A. et al. Direct comparison of the diagnostic capability of cardiac magnetic resonance and endomyocardial biopsy in patients with heart failure. Eur. J. Heart Fail. 15, 166\u2013175 (2013).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio201522_CR56","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1148\/radiol.11091882","volume":"261","author":"KG Ordovas","year":"2011","unstructured":"Ordovas, K. G. & Higgins, C. B. Delayed contrast enhancement on MR images of myocardium: past, present, future. Radiology 261, 358\u2013374 (2011).","journal-title":"Radiology"},{"key":"BFnrcardio201522_CR57","doi-asserted-by":"publisher","first-page":"862","DOI":"10.2214\/AJR.07.3089","volume":"191","author":"A Ichinose","year":"2008","unstructured":"Ichinose, A. et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am. J. Roentgenol. 191, 862\u2013869 (2008).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrcardio201522_CR58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","volume":"189","author":"ED Crouser","year":"2014","unstructured":"Crouser, E. D., Ono, C., Tran, T., He, X. & Raman, S. V. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am. J. Respir. Crit. Care Med. 189, 109\u2013112 (2014).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"BFnrcardio201522_CR59","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/00004728-200209000-00017","volume":"26","author":"O Vignaux","year":"2002","unstructured":"Vignaux, O. et al. Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J. Comput. Assist. Tomogr. 26, 762\u2013767 (2002).","journal-title":"J. Comput. Assist. Tomogr."},{"key":"BFnrcardio201522_CR60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jjcc.2008.03.002","volume":"51","author":"F Matoh","year":"2008","unstructured":"Matoh, F. et al. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J. Cardiol. 51, 179\u2013188 (2008).","journal-title":"J. Cardiol."},{"key":"BFnrcardio201522_CR61","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/RTI.0b013e3182761830","volume":"28","author":"E Watanabe","year":"2013","unstructured":"Watanabe, E. et al. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J. Thorac. Imaging 28, 60\u201366 (2013).","journal-title":"J. Thorac. Imaging"},{"key":"BFnrcardio201522_CR62","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","volume":"6","author":"S Greulich","year":"2013","unstructured":"Greulich, S. et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc. Imaging 6, 501\u2013511 (2013).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"BFnrcardio201522_CR63","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","volume":"100","author":"T Ise","year":"2014","unstructured":"Ise, T. et al. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart 100, 1165\u20131172 (2014).","journal-title":"Heart"},{"key":"BFnrcardio201522_CR64","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s12350-009-9110-0","volume":"16","author":"R Langah","year":"2009","unstructured":"Langah, R., Spicer, K., Gebregziabher, M. & Gordon, L. Effectiveness of prolonged fasting 18f-FDG PET-CT in the detection of cardiac sarcoidosis. J. Nucl. Cardiol. 16, 801\u2013810 (2009).","journal-title":"J. Nucl. Cardiol."},{"key":"BFnrcardio201522_CR65","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2967\/jnumed.111.090662","volume":"53","author":"G Youssef","year":"2012","unstructured":"Youssef, G. et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J. Nucl. Med. 53, 241\u2013248 (2012).","journal-title":"J. Nucl. Med."},{"key":"BFnrcardio201522_CR66","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","volume":"3","author":"N Tahara","year":"2010","unstructured":"Tahara, N. et al. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc. Imaging 3, 1219\u20131228 (2010).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"BFnrcardio201522_CR67","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.2967\/jnumed.107.041574","volume":"48","author":"E Inglese","year":"2007","unstructured":"Inglese, E. et al. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET\/CT. J. Nucl. Med. 48, 1662\u20131669 (2007).","journal-title":"J. Nucl. Med."},{"key":"BFnrcardio201522_CR68","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1007\/s12350-013-9798-8","volume":"20","author":"LC Gormsen","year":"2013","unstructured":"Gormsen, L. C., Christensen, N. L., Bendstrup, E., Tolbod, L. P. & Nielsen, S. S. Complete somatostatin-induced insulin suppression combined with heparin loading does not significantly suppress myocardial 18F-FDG uptake in patients with suspected cardiac sarcoidosis. J. Nucl. Cardiol. 20, 1108\u20131115 (2013).","journal-title":"J. Nucl. Cardiol."},{"key":"BFnrcardio201522_CR69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00259-004-1670-2","volume":"32","author":"M de Groot","year":"2005","unstructured":"de Groot, M., Meeuwis, A. P., Kok, P. J., Corstens, F. H. & Oyen, W. J. Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut. Eur. J. Nucl. Med. Mol. Imaging 32, 98\u2013101 (2005).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"BFnrcardio201522_CR70","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1378\/chest.11-0263","volume":"141","author":"NY Hamzeh","year":"2012","unstructured":"Hamzeh, N. Y., Wamboldt, F. S. & Weinberger, H. D. Management of cardiac sarcoidosis in the United States: a Delphi study. Chest 141, 154\u2013162 (2012).","journal-title":"Chest"},{"key":"BFnrcardio201522_CR71","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.4065\/mcp.2011.0296","volume":"86","author":"AM From","year":"2011","unstructured":"From, A. M., Maleszewski, J. J. & Rihal, C. S. Current status of endomyocardial biopsy. Mayo Clin. Proc. 86, 1095\u20131102 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrcardio201522_CR72","unstructured":"Diagnostic standard and guidelines for sarcoidosis [Japanese]. Jpn. J. Sarcoidosis Granulomatous Disord. 27, 89\u2013102 (2007)."},{"key":"BFnrcardio201522_CR73","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson, M. A. et al. The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool. Sarcoidosis Vasc. Diffuse Lung Dis. 31, 19\u201327 (2014).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"BFnrcardio201522_CR74","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ccm.2008.03.005","volume":"29","author":"US Ayyala","year":"2008","unstructured":"Ayyala, U. S., Nair, A. P. & Padilla, M. L. Cardiac sarcoidosis. Clin. Chest Med. 29, 493\u2013508 (2008).","journal-title":"Clin. Chest Med."},{"key":"BFnrcardio201522_CR75","first-page":"133","volume":"20","author":"Y Kato","year":"2003","unstructured":"Kato, Y. et al. Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc. Diffuse Lung Dis. 20, 133\u2013137 (2003).","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"BFnrcardio201522_CR76","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","volume":"88","author":"Y Yazaki","year":"2001","unstructured":"Yazaki, Y. et al. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am. J. Cardiol. 88, 1006\u20131010 (2001).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201522_CR77","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","volume":"16","author":"K Yodogawa","year":"2011","unstructured":"Yodogawa, K. et al. Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis. Ann. Noninvasive Electrocardiol. 16, 140\u2013147 (2011).","journal-title":"Ann. Noninvasive Electrocardiol."},{"key":"BFnrcardio201522_CR78","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.jjcc.2013.07.007","volume":"62","author":"K Yodogawa","year":"2013","unstructured":"Yodogawa, K. et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J. Cardiol. 62, 320\u2013325 (2013).","journal-title":"J. Cardiol."},{"key":"BFnrcardio201522_CR79","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.amjcard.2004.08.083","volume":"95","author":"CZ Chiu","year":"2005","unstructured":"Chiu, C. Z. et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am. J. Cardiol. 95, 143\u2013146 (2005).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201522_CR80","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2169\/internalmedicine.53.0794","volume":"53","author":"S Nagai","year":"2014","unstructured":"Nagai, S. et al. Treatment with methotrexate and low-dose corticosteroids in sarcoidosis patients with cardiac lesions. Intern. Med. 53, 427\u2013433 (2014).","journal-title":"Intern. Med."},{"key":"BFnrcardio201522_CR81","first-page":"1686","volume":"35","author":"C Barnabe","year":"2008","unstructured":"Barnabe, C., McMeekin, J., Howarth, A. & Martin, L. Successful treatment of cardiac sarcoidosis with infliximab. J. Rheumatol. 35, 1686\u20131687 (2008).","journal-title":"J. Rheumatol."},{"key":"BFnrcardio201522_CR82","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s10067-007-0614-1","volume":"26","author":"I Uthman","year":"2007","unstructured":"Uthman, I., Touma, Z. & Khoury, M. Cardiac sarcoidosis responding to monotherapy with infliximab. Clin. Rheumatol. 26, 2001\u20132003 (2007).","journal-title":"Clin. Rheumatol."},{"key":"BFnrcardio201522_CR83","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung, E. S. et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 107, 3133\u20133140 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201522_CR84","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.amjcard.2005.03.059","volume":"96","author":"A Aizer","year":"2005","unstructured":"Aizer, A. et al. Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am. J. Cardiol. 96, 276\u2013282 (2005).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201522_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCEP.110.958322","volume":"4","author":"D Mehta","year":"2011","unstructured":"Mehta, D. et al. Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation. Circ. Arrhythm. Electrophysiol. 4, 43\u201348 (2011).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"BFnrcardio201522_CR86","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jacc.2012.12.014","volume":"61","author":"AE Epstein","year":"2013","unstructured":"Epstein, A. E. et al. 2012 ACCF\/AHA\/HRS focused update incorporated into the ACCF\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol. 61, e6\u2013e75 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201522_CR87","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","volume":"23","author":"JL Schuller","year":"2012","unstructured":"Schuller, J. L. et al. Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis. J. Cardiovasc. Electrophysiol. 23, 925\u2013929 (2012).","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"BFnrcardio201522_CR88","doi-asserted-by":"publisher","unstructured":"Mohsen, A. et al. Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator. J. Cardiovasc. Electrophysiol. http:\/\/dx.doi.org\/10.1111\/jce.12302 .","DOI":"10.1111\/jce.12302"},{"key":"BFnrcardio201522_CR89","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/europace\/eus316","volume":"15","author":"J Kron","year":"2013","unstructured":"Kron, J. et al. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. Europace 15, 347\u2013354 (2013).","journal-title":"Europace"},{"key":"BFnrcardio201522_CR90","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy, G. H. et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225\u2013237 (2005).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201522_CR91","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJM199103213241201","volume":"324","author":"DS Echt","year":"1991","unstructured":"Echt, D. S. et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N. Engl. J. Med. 324, 781\u2013788 (1991).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201522_CR92","first-page":"e240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy, C. W. et al. 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128, e240\u2013e327 (2013).","journal-title":"Circulation"},{"key":"BFnrcardio201522_CR93","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jjcc.2012.07.013","volume":"60","author":"H Akashi","year":"2012","unstructured":"Akashi, H. et al. Outcome of patients with cardiac sarcoidosis undergoing cardiac transplantation\u2014single-center retrospective analysis. J. Cardiol. 60, 407\u2013410 (2012).","journal-title":"J. Cardiol."},{"key":"BFnrcardio201522_CR94","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1055\/s-2007-979391","volume":"132","author":"T Strecker","year":"2007","unstructured":"Strecker, T., Zimmermann, I. & Wiest, G. H. Pulmonary and cardiac recurrence of sarcoidosis in a heart transplant recipient [German]. Dtsch. Med. Wochenschr. 132, 1159\u20131162 (2007).","journal-title":"Dtsch. Med. Wochenschr."},{"key":"BFnrcardio201522_CR95","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.healun.2005.02.016","volume":"24","author":"JE Yager","year":"2005","unstructured":"Yager, J. E. et al. Recurrence of cardiac sarcoidosis in a heart transplant recipient. J. Heart Lung Transplant. 24, 1988\u20131990 (2005).","journal-title":"J. Heart Lung Transplant."},{"key":"BFnrcardio201522_CR96","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.hrthm.2012.10.019","volume":"10","author":"DG Dechering","year":"2013","unstructured":"Dechering, D. G. et al. Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy. Heart Rhythm 10, 158\u2013164 (2013).","journal-title":"Heart Rhythm"},{"key":"BFnrcardio201522_CR97","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","volume":"9","author":"BP Betensky","year":"2012","unstructured":"Betensky, B. P. et al. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators. Heart Rhythm 9, 884\u2013891 (2012).","journal-title":"Heart Rhythm"}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.22","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2015.22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T01:27:13Z","timestamp":1691371633000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2015.22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["BFnrcardio201522"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2015.22","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]},"assertion":[{"value":"24 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}